Activation of LIM Kinases by Myotonic Dystrophy Kinase-related Cdc42-binding Kinase α

Tomoyuki Sumi, Kunio Matsumoto, Akihiro Shibuya, Toshikazu Nakamura

Journal of Biological Chemistry · 2001 · 111 citations · 19 references

DOIFull text

Open access

Concepts

Abstract

LIM kinases (LIMK1 and LIMK2) regulate actin cytoskeletal reorganization through cofilin phosphorylation downstream of distinct Rho family GTPases. Pak1 and ROCK, respectively, activate LIMK1 and LIMK2 downstream of Rac and Rho; however, an effector protein kinase for LIMKs downstream of Cdc42 remains to be defined. We now report evidence that LIMK1 and LIMK2 activities toward cofilin phosphorylation are stimulated in cells by the co-expression of myotonic dystrophy kinase-related Cdc42-binding kinase α (MRCKα), an effector protein kinase of Cdc42. In vitro, MRCKα phosphorylated the protein kinase domain of LIM kinases, and the site in LIMK2 phosphorylated by MRCKα proved to be threonine 505 within the activation segment. Expression of MRCKα induced phosphorylation of actin depolymerizing factor (ADF)/cofilin in cells, whereas MRCKα-induced ADF/cofilin phosphorylation was inhibited by the co-expression with the protein kinase-deficient form of LIM kinases. These results indicate that MRCKα phosphorylates and activates LIM kinases downstream of Cdc42, which in turn regulates the actin cytoskeletal reorganization through the phosphorylation and inactivation of ADF/cofilin. LIM kinases (LIMK1 and LIMK2) regulate actin cytoskeletal reorganization through cofilin phosphorylation downstream of distinct Rho family GTPases. Pak1 and ROCK, respectively, activate LIMK1 and LIMK2 downstream of Rac and Rho; however, an effector protein kinase for LIMKs downstream of Cdc42 remains to be defined. We now report evidence that LIMK1 and LIMK2 activities toward cofilin phosphorylation are stimulated in cells by the co-expression of myotonic dystrophy kinase-related Cdc42-binding kinase α (MRCKα), an effector protein kinase of Cdc42. In vitro, MRCKα phosphorylated the protein kinase domain of LIM kinases, and the site in LIMK2 phosphorylated by MRCKα proved to be threonine 505 within the activation segment. Expression of MRCKα induced phosphorylation of actin depolymerizing factor (ADF)/cofilin in cells, whereas MRCKα-induced ADF/cofilin phosphorylation was inhibited by the co-expression with the protein kinase-deficient form of LIM kinases. These results indicate that MRCKα phosphorylates and activates LIM kinases downstream of Cdc42, which in turn regulates the actin cytoskeletal reorganization through the phosphorylation and inactivation of ADF/cofilin. LIM kinase actin depolymerizing factor pleckstrin homology domain protein kinase (mutant LIMK2 with a deleted N-terminal half containing both LIM and PDZ domains) glutathioneS-transferase hemagglutinin myotonic dystrophy kinase-related Cdc42-binding kinase α polymerase chain reaction kinase-dead fetal bovine serum minimum essential medium polyacrylamide gel electrophoresis LIM kinase (LIMK)1 is a member of a novel class of protein serine/threonine/tyrosine kinases with characteristic structural features composed of two LIM domains and a PDZ domain (1Mizuno K. Okano I. Ohashi K. Nunoue K. Kuma K. Miyata T. Nakamura T. Oncogene. 1994; 9: 1605-1612PubMed Google Scholar, 2Ohashi K. Toshima J. Tajinda K. Nakamura T. Mizuno K. J. Biochem. 1994; 116: 636-642Crossref PubMed Scopus (36) Google Scholar, 3Bernard O. Ganiatsas S. Kannourakis G. Dringen R. Cell Growth Differ. 1994; 5: 1159-1171PubMed Google Scholar, 4Nunoue K. Ohashi K. Okano I. Mizuno K. Oncogene. 1995; 11: 701-710PubMed Google Scholar, 5Okano I. Hiraoka J. Otera H. Nunoue K. Ohashi K. Iwashita S. Hirai M. Mizuno K. J. Biol. Chem. 1995; 270: 31321-31330Abstract Full Text Full Text PDF PubMed Scopus (169) Google Scholar, 6Ikebe C. Ohashi K. Fujimori T. Bernard O. Noda T. Robertson E.J. Mizuno K. Genomics. 1997; 46: 504-508Crossref PubMed Scopus (32) Google Scholar, 7Koshimizu U. Takahashi H. Yoshida M.C. Nakamura T. Biochem. Biophys. Res. Commun. 1997; 241: 243-250Crossref PubMed Scopus (21) Google Scholar). Previous studies showed that two closely related LIMKs, LIMK1 and LIMK2, regulate actin cytoskeletal reorganization; LIMK-induced actin cytoskeletal rearrangement is mediated by cofilin, an actin depolymerizing factor of actin filaments (8Arber S. Barbayannis F.A. Hanser H. Schneider C. Stanyon C.A. Bernard O. Caroni P. Nature. 1998; 393: 805-809Crossref PubMed Scopus (1154) Google Scholar, 9Yang N. Higuchi O. Ohashi K. Nagata K. Wada A. Kangawa K. Nishida E. Mizuno K. Nature. 1998; 393: 809-812Crossref PubMed Scopus (1058) Google Scholar, 10Sumi T. Matsumoto K. Takai Y. Nakamura T. J. Cell Biol. 1999; 147: 1519-1532Crossref PubMed Scopus (310) Google Scholar). The actin depolymerizing factor (ADF)/cofilin family is responsible for the turnover of actin filaments and probably is a potential downstream effector of signaling pathways that evoke reorganization of the actin cytoskeleton (11Bamburg J.R. Annu. Rev. Cell Dev. Biol. 1999; 15: 185-230Crossref PubMed Scopus (833) Google Scholar, 12Bamburg J.R. McGough A. Ono S. Trends Cell Biol. 1999; 9: 364-370Abstract Full Text Full Text PDF PubMed Scopus (325) Google Scholar, 13Carlier M.-F. Ressad F. Pantaloni D. J. Biol. Chem. 1999; 274: 33827-33830Abstract Full Text Full Text PDF PubMed Scopus (172) Google Scholar). Activated LIMK catalyzes phosphorylation of an N-terminal third serine residue of cofilin and inhibits its activity to depolymerize actin filaments, thereby leading to stabilization of actin filaments. Our studies show that the XLIMK, the Xenopuscounterpart of mammalian LIMK (14Takahashi T. Aoki S. Nakamura T. Koshimizu U. Matsumoto K. Nakamura T. Dev. Dyn. 1997; 209: 196-205Crossref PubMed Scopus (19) Google Scholar), is critically involved in the progression of progesterone-induced Xenopus oocyte maturation through Xenopus cofilin phosphorylation (15Takahashi T. Koshimizu U. Abe H. Obinata T. Nakamura T. Dev. Biol. 2001; 229: 554-567Crossref PubMed Scopus (28) Google Scholar). Therefore, LIMKs may be a key component of a fundamental signal transduction system that connects the extracellular stimuli that alter actin cytoskeletal rearrangements. The Rho family GTPases (including Rho, Rac, and Cdc42) are key regulators in signaling pathways that link extra- and intracellular stimuli to actin cytoskeletal reorganization (16Hall A. Science. 1998; 279: 509-514Crossref PubMed Scopus (5200) Google Scholar, 17Schmid A. Hall M.N. Annu. Rev. Cell Dev. Biol. 1998; 14: 305-338Crossref PubMed Scopus (371) Google Scholar, 18Kaibuchi K. Kuroda S. Amano M. Annu. Rev. Biochem. 1999; 68: 459-486Crossref PubMed Scopus (886) Google Scholar, 19Takai Y. Sasaki T. Matozaki T. Physiol. Rev. 2001; 81: 153-208Crossref PubMed Scopus (2048) Google Scholar). Among several downstream effectors of Rho family GTPases that are involved in regulating actin cytoskeleton, LIMK1 and LIMK2 play a role in actin cytoskeletal reorganization downstream of distinct Rho family GTPases (8Arber S. Barbayannis F.A. Hanser H. Schneider C. Stanyon C.A. Bernard O. Caroni P. Nature. 1998; 393: 805-809Crossref PubMed Scopus (1154) Google Scholar, 9Yang N. Higuchi O. Ohashi K. Nagata K. Wada A. Kangawa K. Nishida E. Mizuno K. Nature. 1998; 393: 809-812Crossref PubMed Scopus (1058) Google Scholar, 10Sumi T. Matsumoto K. Takai Y. Nakamura T. J. Cell Biol. 1999; 147: 1519-1532Crossref PubMed Scopus (310) Google Scholar). LIMK1 is regulated by Rac and Cdc42, whereas LIMK2 is regulated by Rho and Cdc42; LIMKs have a definitive role in the Rho family GTPases-induced actin cytoskeletal rearrangement (8Arber S. Barbayannis F.A. Hanser H. Schneider C. Stanyon C.A. Bernard O. Caroni P. Nature. 1998; 393: 805-809Crossref PubMed Scopus (1154) Google Scholar, 9Yang N. Higuchi O. Ohashi K. Nagata K. Wada A. Kangawa K. Nishida E. Mizuno K. Nature. 1998; 393: 809-812Crossref PubMed Scopus (1058) Google Scholar, 10Sumi T. Matsumoto K. Takai Y. Nakamura T. J. Cell Biol. 1999; 147: 1519-1532Crossref PubMed Scopus (310) Google Scholar). Recent studies revealed that Pak1 activates LIMK1 downstream of Rac1 (20Edwards D.C. Sanders L.C. Bokoch G.M. Gill G.N. Nat. Cell Biol. 1999; 1: 253-259Crossref PubMed Scopus (840) Google Scholar), and ROCK activates LIMK2 downstream of RhoA (21Maekawa M. Ishizaki T. Boku S. Watanabe N. Fujita A. Iwamatsu A. Obinata T. Ohashi K. Mizuno K. Narumiya S. Science. 1999; 285: 895-898Crossref PubMed Scopus (1274) Google Scholar, 22Sumi T. Matsumoto K. Nakamura T. J. Biol. Chem. 2001; 276: 670-676Abstract Full Text Full Text PDF PubMed Scopus (245) Google Scholar). However, an effector protein kinase that phosphorylates/activates LIMKs downstream of Cdc42 remained to be defined. We now report that myotonic dystrophy kinase-related Cdc42-binding kinase α (MRCKα), a Cdc42-dependent protein kinase (23Leung T. Chen X.-Q. Tan I. Manser E. Lim L. Mol. Cell. Biol. 1998; 18: 130-140Crossref PubMed Scopus (220) Google Scholar), activates both LIMK1 and LIMK2 downstream of Cdc42. Our results define a signal transduction pathway wherein MRCKα activates LIMK1 and LIMK2 downstream of Cdc42, which in turn regulates the actin cytoskeletal reorganization through phosphorylation and inactivation of cofilin. Anti-hemagglutinin (HA) monoclonal antibody (12CA5) and anti-Myc monoclonal antibody (9E10) were purchased from Roche Molecular Biochemicals. Anti-cofilin polyclonal antibody was purchased from Cytoskeleton Inc. (Denver, CO). Y-27632 was generously provided by WelFide Co. (Osaka, Japan). The expression plasmids for HA-tagged LIMK1, LIMK2 and its mutants, glutathione S-transferase (GST)-fused cofilin, and GST-fused LIMK protein kinase domain (PK) were constructed as described elsewhere (10Sumi T. Matsumoto K. Takai Y. Nakamura T. J. Cell Biol. 1999; 147: 1519-1532Crossref PubMed Scopus (310) Google Scholar, 22Sumi T. Matsumoto K. Nakamura T. J. Biol. Chem. 2001; 276: 670-676Abstract Full Text Full Text PDF PubMed Scopus (245) Google Scholar). Expression plasmids for Myc-tagged ROCK and its mutants were kindly provided by Dr. S. Narumiya (Kyoto University, Kyoto, Japan). Expression plasmid for Cdc42V12 was kindly provided by Dr. Y. Takai (Osaka University, Osaka, Japan). To generate the plasmid encoding for full-length MRCKα (amino acids 1–1732), partial rat MRCKα cDNA fragments were cloned by reverse transcriptase-PCR using a set of the following primers: A fragment, forward, 5′-GAGTCACAGCAGGTCCC-3′, and reverse, 5′-GGGCAGATTGCAACTCGAGTC-3′; B fragment, forward, 5′-CATGTCAGCTAGACTCGAGTT-3′, and reverse, 5′-CACACACAGGCAGGACA-3′; C fragment, forward, 5′-CGACAGCACTCTACCCC-3′, and reverse, 5′-CTGCGGCCGCTCATGGATCCCAGCTCC-3′. These PCR products were digested with the following enzymes: A fragment, AatII andXhoI; B fragment, XhoI and SacI; C fragment, SacI and NotI. The digested fragments were ligated to AatII- and NotI-digested pEF-BOS-myc-MRCK-ΔC. To generate plasmids encoding MRCK-ΔC (amino acids 1–574), rat MRCKα cDNA fragment was cloned by reverse transcriptase-PCR using a set of the following primers: forward, 5′-GCGGATCCATGTCTGGAGAAGTGCGTTTGA-3′, and reverse, 5′-GGGGATCCTCACAGTTTCCTCTGACAGTGTGCG-3′. The PCR product digested withBamHI was ligated to the BamHI-digested pEF-BOS-myc vector (10Sumi T. Matsumoto K. Takai Y. Nakamura T. J. Cell Biol. 1999; 147: 1519-1532Crossref PubMed Scopus (310) Google Scholar). The cDNA for the kinase defective mutant of MRCK-ΔC (kinase-dead (KD)) was constructed to introduce substitution of the 106th Lys with Ala, using a site-directed mutagenesis kit (CLONTECH, Palo Alto, CA). The authenticity of these expression plasmids was confirmed by nucleotide sequence analysis. COS-7 cells were maintained in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum (FBS). HeLa cells were maintained in minimal essential medium (MEM) supplemented with FBS and non-essential amino acids. Subconfluent COS-7 cells were trypsinized and resuspended in phosphate-buffered saline, and 106 cells were transfected with 10 μg of plasmid DNA by electroporation using a Gene Pulser (Bio-Rad) according to the manufacturer's instructions. Cells were cultured for 36 h in Dulbecco's modified Eagle's medium supplemented with 10% FBS. HeLa cells were cultured for 12 h at a density of 6 × 103/cm2 and then further cultured for 16 h in serum-free MEM. The cells were transfected in Opti-MEM containing 3 μg of plasmid DNA complexed with LipofectAMINE. After a 2-h incubation, the medium was replaced with serum-free MEM, and the cells were cultured for 22 h. COS-7 cells were transiently transfected with expression plasmid as described above. The cells were lysed in 1 ml of lysis buffer consisting of 50 mm Tris-HCl (pH 7.5), 0.5m NaCl, 25 mm β-glycerophosphate, 10 mm NaF, 1 mm Na3VO4, 1% Triton X-100, 10% glycerol, 1 mm phenylmethylsulfonyl fluoride, and 2 μg/ml leupeptin and aprotinin and incubated on ice for 30 min. After centrifugation, the supernatant was preadsorbed with 15 μl of protein G-Sepharose (Amersham Pharmacia Biotech, Little Chalfont, UK) for 1 h at 4 °C and centrifuged to remove protein G-Sepharose, and the supernatant was then incubated for 3 h at 4 °C with anti-HA or anti-Myc antibody and 5 μl of protein G-Sepharose. Protein G-Sepharose beads were washed three times with lysis buffer and dissolved in the sample buffer for SDS-PAGE. The immunoprecipitates and cell lysates were separated by SDS-PAGE, electroblotted onto polyvinylidene difluoride membranes (Bio-Rad), and probed with anti-HA and anti-Myc antibody as described elsewhere (10Sumi T. Matsumoto K. Takai Y. Nakamura T. J. Cell Biol. 1999; 147: 1519-1532Crossref PubMed Scopus (310) Google Scholar,22Sumi T. Matsumoto K. Nakamura T. J. Biol. Chem. 2001; 276: 670-676Abstract Full Text Full Text PDF PubMed Scopus (245) Google Scholar). Proteins reacting with these antibodies were detected using ECL enhanced chemiluminescence (Amersham Pharmacia Biotech). For protein kinase assay, immunoprecipitates bound to protein G-Sepharose were washed three times with kinase buffer consisting of 50 mm Hepes-NaOH (pH 7.5), 25 mmβ-glycerophosphate, 5 mm MgCl2, 5 mm MnCl2, 10 mm NaF, and 1 mm Na3VO4 and then incubated for 20 min at 30 °C in 15 μl of kinase buffer containing 50 μm ATP, 5 μCi of [γ-32P]ATP (6000 Ci/mmol, PerkinElmer Life Sciences), and 6 μg of GST-cofilin or 2 μg of GST-PK as substrate. After incubation for 20 min at 30 °C, the reaction was terminated by heat treatment (100 °C for 3 min) in sample buffer for SDS-PAGE, subjected to SDS-PAGE, and analyzed by autoradiography. The transfected HeLa cells were dissolved in two-dimensional lysis buffer composed of 9.5 m urea, 2% Triton X-100, 2% ampholine (pH 3.5–10), and 5% 2-mercaptoethanol and subjected to non-equilibrium pH gradient electrophoresis (NEpHGE) (24O'Farrell P.Z. Goodman H.M. O'Farrell P.H. Cell. 1977; 12: 1133-1141Abstract Full Text PDF PubMed Scopus (2582) Google Scholar). SDS-PAGE was carried out in a 12.5% polyacrylamide gel for the second dimension. Proteins were electroblotted onto polyvinylidene difluoride membranes, probed with anti-cofilin antibody, and then detected using ECL enhanced chemiluminescence. The spot densities of immunoblots were analyzed using NIH Image software (Wayne Rasband Analytics, National Institutes of Health). We reported earlier that the activity of the LIM kinases, LIMK1 and LIMK2, is distinctly regulated by Rho family GTPases (10Sumi T. Matsumoto K. Takai Y. Nakamura T. J. Cell Biol. 1999; 147: 1519-1532Crossref PubMed Scopus (310) Google Scholar). ROCK, a Rho-dependent protein kinase, specifically activates LIMK2 but not LIMK1 downstream of Rho (22Sumi T. Matsumoto K. Nakamura T. J. Biol. Chem. 2001; 276: 670-676Abstract Full Text Full Text PDF PubMed Scopus (245) Google Scholar). To further confirm the specific activation pathway of LIM kinases by Rho family GTPases, we examined the effects of Y-27632, a specific inhibitor of ROCK, on the activation of LIM kinases by Cdc42 (Fig. 1). Consistent with our previous data (10Sumi T. Matsumoto K. Takai Y. Nakamura T. J. Cell Biol. 1999; 147: 1519-1532Crossref PubMed Scopus (310) Google Scholar), LIMK1 activity toward cofilin phosphorylation was stimulated 1.8-fold when co-expressed with the dominant active form of Cdc42 (Cdc42V12) (Fig. 1 A), whereas the addition of Y-27632 did not affect the LIMK1 activity enhanced by Cdc42V12. Likewise, did not LIMK1 activity in cells LIMK1 the in cells LIMK2 Y-27632 inhibited LIMK2 activity to the half Rho-dependent LIMK2 activation was by Y-27632 treatment (22Sumi T. Matsumoto K. Nakamura T. J. Biol. Chem. 2001; 276: 670-676Abstract Full Text Full Text PDF PubMed Scopus (245) Google Scholar), LIMK2 activity is regulated by pathways in LIMK2 was co-expressed with LIMK2 activity was stimulated (Fig. 1 of LIMK2 by Cdc42V12 was inhibited by however, Y-27632 did not LIMK2 activity to the in cells LIMK2 wherein ROCK is inhibited in the of Y-27632, expression of Cdc42V12 LIMK2 these that LIM kinases are regulated by protein that from ROCK downstream of Cdc42. To the protein kinase of LIM kinases, we for the effector protein kinases of Cdc42. We that be a protein kinase of LIM kinase, a key role in of downstream of Cdc42 and is related to Rho (23Leung T. Chen X.-Q. Tan I. Manser E. Lim L. Mol. Cell. Biol. 1998; 18: 130-140Crossref PubMed Scopus (220) Google Scholar). To activate LIM kinases downstream of Cdc42, we constructed expression plasmids for MRCKα MRCK-ΔC is deleted with the containing and a amino involved in in the protein kinase and is to in a kinase-deficient in 2 co-expression of MRCK-ΔC stimulated LIMK1 activity toward cofilin Likewise, LIMK2 activity was stimulated by the co-expression with MRCK-ΔC (Fig. 2 These effects of MRCK-ΔC on LIMK1 and LIMK2 on protein kinase the kinase-dead form of MRCK-ΔC did not LIM kinases We that the dominant active form of ROCK activates both LIMK1 and LIMK2, whereas the ROCK specifically activates LIMK2 but not the half containing the and domains of ROCK is to specific (22Sumi T. Matsumoto K. Nakamura T. J. Biol. Chem. 2001; 276: 670-676Abstract Full Text Full Text PDF PubMed Scopus (245) Google Scholar). MRCKα domains consisting of and domains within the (Fig. 2 these domains play an role in and (23Leung T. Chen X.-Q. Tan I. Manser E. Lim L. Mol. Cell. Biol. 1998; 18: 130-140Crossref PubMed Scopus (220) Google Scholar, X.-Q. Tan I. T. Lim L. J. Biol. Chem. 1999; 274: Full Text Full Text PDF PubMed Scopus Google Scholar). Therefore, we full-length MRCKα specifically activate LIMK1 or Consistent with previous (22Sumi T. Matsumoto K. Nakamura T. J. Biol. Chem. 2001; 276: 670-676Abstract Full Text Full Text PDF PubMed Scopus (245) Google Scholar), LIMK2 but not LIMK1 activity was specifically by the co-expression of ROCK In LIMK1 and LIMK2 activities in cells MRCKα were respectively, to a and in cells LIMK1 or LIMK2 (Fig. 2 These results indicate that MRCKα activates both LIMK1 and LIMK2 activity as an protein activation of LIMK2 by ROCK is mediated by the phosphorylation of in the activation within the protein kinase domain of LIMK2 (22Sumi T. Matsumoto K. Nakamura T. J. Biol. Chem. 2001; 276: 670-676Abstract Full Text Full Text PDF PubMed Scopus (245) Google Scholar), we activation of LIM kinases by MRCKα be mediated through phosphorylation of the protein kinase domain of LIM kinases. LIMK2 activity was stimulated with the co-expression with MRCK-ΔC the kinase activity of the mutant with the deleted N-terminal half containing LIM and PDZ domains) was stimulated by with the co-expression of LIMK2 activation is mediated by the protein kinase domain of To are phosphorylated by we GST-fused of LIMK1 and The were subjected to an in (Fig. 3 MRCK-ΔC phosphorylated the protein kinase domain of LIMKs, whereas did not protein phosphorylation of MRCKα a with Rho (23Leung T. Chen X.-Q. Tan I. Manser E. Lim L. Mol. Cell. Biol. 1998; 18: 130-140Crossref PubMed Scopus (220) Google Scholar, N. N. Y. Amano M. M. Kuroda S. Y. T. Lim L. K. 5: PubMed Scopus Google and phosphorylates a threonine residue in LIMK1, in LIMK2) within the activation of LIM kinases (22Sumi T. Matsumoto K. Nakamura T. J. Biol. Chem. 2001; 276: 670-676Abstract Full Text Full Text PDF PubMed Scopus (245) Google Scholar, K. Nagata K. M. Ishizaki T. Narumiya S. Mizuno K. J. Biol. Chem. Scholar), we that threonine residue be a site phosphorylated by To we MRCK-ΔC with or and examined the potential of MRCK-ΔC to activate mutant LIMK2 (Fig. 3 The kinase activity of LIMK2 was enhanced to a the by co-expression with MRCK-ΔC with phosphorylation of In activation of phosphorylation was by co-expression with The kinase activity of mutant was that of LIMK2, the phosphorylation of However, the kinase activity of was not by co-expression with These results that MRCKα activates LIMK2 through phosphorylation in the protein kinase domain of to both LIMK1 and LIMK2 as downstream effectors on signal transduction toward cofilin We from transfected HeLa cells and subjected to two-dimensional gel The phosphorylated and ADF/cofilin was detected using and ADF/cofilin was as the was in 4 in HeLa cells, ADF/cofilin was not phosphorylated or was In when LIMK1 was in cells, phosphorylated ADF/cofilin to of the ADF/cofilin. of ADF/cofilin was in cells the protein kinase-deficient form of LIMK1 results were when LIMK2 was in ADF/cofilin to of the whereas phosphorylated ADF/cofilin was not in cells the when MRCKα was in cells, phosphorylated ADF/cofilin to of the ADF/cofilin (Fig. 4 MRCKα not phosphorylates ADF/cofilin not MRCKα-induced phosphorylation of ADF/cofilin may be mediated LIM kinases. Consistent with MRCKα-induced phosphorylation of ADF/cofilin was respectively, to and of the ADF/cofilin with the co-expression with and when MRCKα was co-expressed with both and MRCKα-induced ADF/cofilin phosphorylation was These results indicate that LIMK1 and LIMK2 as downstream effectors of MRCKα and play a role in MRCKα-induced actin cytoskeletal reorganization through inactivation of ADF/cofilin. In the we that a downstream effector of Cdc42, phosphorylates and activates both LIMK1 and LIMK2 and in the activation of LIM kinases downstream of Cdc42. with previous that LIMK1 is by Pak1 downstream of Rac1 (20Edwards D.C. Sanders L.C. Bokoch G.M. Gill G.N. Nat. Cell Biol. 1999; 1: 253-259Crossref PubMed Scopus (840) Google and that ROCK specifically activates LIMK2 downstream of RhoA (22Sumi T. Matsumoto K. Nakamura T. J. Biol. Chem. 2001; 276: 670-676Abstract Full Text Full Text PDF PubMed Scopus (245) Google Scholar), these define signal transduction pathways through which Rho family GTPases regulate actin The actin cytoskeletal in cells in and of Cell. Full Text Full Text PDF PubMed Scopus Google Scholar, Cell. Full Text Full Text PDF PubMed Scopus Google Scholar). The and of actin filaments are regulated both and these The reorganization of actin cytoskeleton with extracellular stimuli is regulated through distinct Rho family GTPases and specific effectors (16Hall A. Science. 1998; 279: 509-514Crossref PubMed Scopus (5200) Google Scholar, 17Schmid A. Hall M.N. Annu. Rev. Cell Dev. Biol. 1998; 14: 305-338Crossref PubMed Scopus (371) Google Scholar, 18Kaibuchi K. Kuroda S. Amano M. Annu. Rev. Biochem. 1999; 68: 459-486Crossref PubMed Scopus (886) Google Scholar, 19Takai Y. Sasaki T. Matozaki T. Physiol. Rev. 2001; 81: 153-208Crossref PubMed Scopus (2048) Google Scholar). In of actin signal transduction and may play distinct role in regulating actin that in a of for LIMK1 a role in whereas LIMK2 a role in and (8Arber S. Barbayannis F.A. Hanser H. Schneider C. Stanyon C.A. Bernard O. Caroni P. Nature. 1998; 393: 805-809Crossref PubMed Scopus (1154) Google Scholar, 9Yang N. Higuchi O. Ohashi K. Nagata K. Wada A. Kangawa K. Nishida E. Mizuno K. Nature. 1998; 393: 809-812Crossref PubMed Scopus (1058) Google Scholar, 10Sumi T. Matsumoto K. Takai Y. Nakamura T. J. Cell Biol. 1999; 147: 1519-1532Crossref PubMed Scopus (310) Google Scholar). Likewise, expression of LIMK1 and LIMK2 (1Mizuno K. Okano I. Ohashi K. Nunoue K. Kuma K. Miyata T. Nakamura T. Oncogene. 1994; 9: 1605-1612PubMed Google Scholar, 2Ohashi K. Toshima J. Tajinda K. Nakamura T. Mizuno K. J. Biochem. 1994; 116: 636-642Crossref PubMed Scopus (36) Google Scholar, 3Bernard O. Ganiatsas S. Kannourakis G. Dringen R. Cell Growth Differ. 1994; 5: 1159-1171PubMed Google Scholar, 4Nunoue K. Ohashi K. Okano I. Mizuno K. Oncogene. 1995; 11: 701-710PubMed Google Scholar, 5Okano I. Hiraoka J. Otera H. Nunoue K. Ohashi K. Iwashita S. Hirai M. Mizuno K. J. Biol. Chem. 1995; 270: 31321-31330Abstract Full Text Full Text PDF PubMed Scopus (169) Google Scholar, 6Ikebe C. Ohashi K. Fujimori T. Bernard O. Noda T. Robertson E.J. Mizuno K. Genomics. 1997; 46: 504-508Crossref PubMed Scopus (32) Google Scholar, 7Koshimizu U. Takahashi H. Yoshida M.C. Nakamura T. Biochem. Biophys. Res. Commun. 1997; 241: 243-250Crossref PubMed Scopus (21) Google as as of protein kinases for LIMKs in and cells may further the or cell of actin We Dr. S. Narumiya (Kyoto University, Kyoto, for plasmids of ROCK and WelFide Co. (Osaka, for We are to Dr. Y. Takai (Osaka University, Osaka, for the Cdc42V12 plasmid and to M. for and

References

19